Ryman’s turnaround is well under way: Forsyth Barr

Ryman’s turnaround is well under way: Forsyth Barr
Forsyth Barr's Aaron Ibbotson rates Ryman shares as "outperform". (Image: Forsyth Barr)
Jenny Ruth
Forsyth Barr analyst Aaron Ibbotson has taken a deep dive into Ryman Healthcare‘s debt position and its turnaround strategy and concluded it is “changing its stripes more than the market is giving it credit for”.The market has certainly exhibited extreme disillusion with the stock in recent weeks.Ryman shares fell as low as $4.82 after it completed its $902 million capital raising, compared with the rights issue price of $5 per new share and $6.40 before the mid-February announcement.The shares closed at $5.22 on Tuesday.A goo...

More Markets

NZ sharemarket has its best week of 2024
Markets Market Close

NZ sharemarket has its best week of 2024

The S&P/NZX 50 closed at 12,134.97, up 76.68 points or 0.64%.

Graham Skellern 12 Jul 2024
Smartpay investors vote in favour of 25% director fees increase
Markets

Smartpay investors vote in favour of 25% director fees increase

Smartpay is increasing the amount of money available to pay directors as it looks to grow.

John Anthony 12 Jul 2024
Warehouse Group to cut jobs at its head office
Retail

Warehouse Group to cut jobs at its head office

The company had already indicated last month that it was looking to trim staffing.

Gregor Thompson 12 Jul 2024
Infratil retail offer brings in $275m
Markets

Infratil retail offer brings in $275m

Offer was part of a wider $1.275 billion equity raising.

John Anthony 12 Jul 2024